Top Banner
Hypertensive Disorders Hypertensive Disorders in Pregnancy in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Prof. of Obstetrics & Gynecology Gynecology
36

Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Mar 26, 2015

Download

Documents

Zoe Owens
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Hypertensive Disorders Hypertensive Disorders in Pregnancyin Pregnancy

Azza AlyamaniAzza Alyamani

Prof. of Obstetrics & GynecologyProf. of Obstetrics & Gynecology

Page 2: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

ClassificationClassification

Women who are pregnant and hypertensiveWomen who are pregnant and hypertensive

must be divided into :must be divided into :

* chronic hypertension* chronic hypertension..

* pregnancy induced hypertension (PIH)* pregnancy induced hypertension (PIH)

or gestational hypertension.or gestational hypertension.

those with PIH further subdivided :those with PIH further subdivided :

* * proteinuric PIHproteinuric PIH (preeclampsia) (preeclampsia)minorityminority

* * non-proteinuric PIHnon-proteinuric PIH majoritymajority

Page 3: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Therefore :Therefore :

women with hypertension in pregnancy are women with hypertension in pregnancy are classified as having:classified as having:

1. preeclampsia (proteinuric hypertension).1. preeclampsia (proteinuric hypertension). 2. non 2. non –– proteinuric hypertension. proteinuric hypertension. 3. chronic hypertension:3. chronic hypertension: • •primary (essential) hypertension. 95%.primary (essential) hypertension. 95%. • •secondary hypertension.5%.secondary hypertension.5%. ..renal dis...renal dis. ..adrenal dis...adrenal dis. ..hyperthyroidism...hyperthyroidism.

The aetiology and management of the three The aetiology and management of the three conditions are different . conditions are different .

Page 4: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Incidence:Incidence:

Worldwide , maternal mortality from hypertensive Worldwide , maternal mortality from hypertensive disease accounts for :disease accounts for : 100.000 deaths per year100.000 deaths per year..

preeclampsia occurs in preeclampsia occurs in 5% .5% . non non –– proteinuric PIH proteinuric PIH 15%.15%.

it accounts to it accounts to 15 15 –– 20% 20% of maternal mortality in of maternal mortality in the developed cuonteris.the developed cuonteris.

Page 5: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Definition:Definition: pregnancy induced hypertension (PIH) is :pregnancy induced hypertension (PIH) is :

Hypertension that occurs after Hypertension that occurs after 20 weeks 20 weeks gestation gestation and unrelated to other pathology.and unrelated to other pathology.

protienuria is the excretion of protienuria is the excretion of 300mg300mg or more of or more of protein in 24 hours urine.protein in 24 hours urine.

hypertension and protienuria define hypertension and protienuria define preeclampsia.preeclampsia.

Page 6: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Preeclampsia :Preeclampsia :

** is a multisystem disorder involving the is a multisystem disorder involving the placentaplacenta , , liver liver ,, kidneys kidneys ,, blood blood ,, neurological neurological and and

cardiovascularcardiovascular systems. systems.

** both maternal and fetal morbidity / mortality are both maternal and fetal morbidity / mortality are more likely to occur with more likely to occur with early early –– onset disease onset disease as;as;

placental abruption ,acute renal failure ,cerebral placental abruption ,acute renal failure ,cerebral Hge ,DIC and IUGR ,prematurity Hge ,DIC and IUGR ,prematurity as delivery is as delivery is

the only cure.the only cure.

therefore , ANC is directed towards identifying therefore , ANC is directed towards identifying women with hypertension and protienuria.women with hypertension and protienuria.

Page 7: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

** severity ranges from : severity ranges from :• a mild disorder (transient hypertension

in the later part of the pregnancy) to• a life-threatening disorder with seizure

HELLP syndrome, fetal hypoxia, and growth retardation.

• ** more severe disease: more severe disease: 0.5 per 10000.5 per 1000 deliveries deliveries

Page 8: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Chronic Hypertension :Chronic Hypertension :

is the presence of persistent hypertension of is the presence of persistent hypertension of whatever cause , whatever cause , before 20 weeksbefore 20 weeks gestation gestation

oror persistent hypertension beyond persistent hypertension beyond 6 weeks 6 weeks postpartum.postpartum.

sustained bl. p of sustained bl. p of 140/90140/90 mmHg or > on two mmHg or > on two occasions 6 hours apart is considered occasions 6 hours apart is considered

hypertensive.hypertensive.

Page 9: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

AetiologyAetiology

Pregnancy induced hypertension (PIH)Pregnancy induced hypertension (PIH)

Preeclampsia:Preeclampsia:

is unknown , believed to be involved :is unknown , believed to be involved :

= immune maladaptation.= immune maladaptation.

= placental ischemia.= placental ischemia.

= oxidative stress.= oxidative stress.

= genetic predisposition.= genetic predisposition.

Page 10: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Genetic Predisposition

Faulty interplay bet. invading trophoblast and decidua

Decreased bl. supply to feto-placental unit

Release of circulating factors

Endothelial cell alteration

Hypertension Proteinuria IUGR

Page 11: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

ManagementManagement

Screening for preeclampsia :Screening for preeclampsia :Risk FactorsRisk Factors 1. +ve family history in the first 1. +ve family history in the first ––degree relativedegree relative increase theincrease the risk of PET 4 risk of PET 4 –– 8 fold. 8 fold. 2. primiparety 2. primiparety 3. medical disorders as :3. medical disorders as : * history of PET.* history of PET. * chronic hypertension.* chronic hypertension. * diabetes.* diabetes. * obesity.* obesity. * antiphospholipid syndrome.* antiphospholipid syndrome. * molar pregnancy.* molar pregnancy. * multiple pregnancy.* multiple pregnancy. * hydrops fetalis.* hydrops fetalis.

Page 12: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Screening and assessment for chronicScreening and assessment for chronic

hypertension :hypertension :

Women who is found to be hypertensive before Women who is found to be hypertensive before pregnancy can be advised about :pregnancy can be advised about :

11. weight loss.. weight loss.

22. restrict salt and alcohol intake.. restrict salt and alcohol intake.

33. change her antihypertensive agents , diuretics ,. change her antihypertensive agents , diuretics ,

angiotensin-converting enzyme (ACE) inhibitorsangiotensin-converting enzyme (ACE) inhibitors

and and ββ blockers to other alternatives. blockers to other alternatives.

Page 13: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

DiagnosisDiagnosis

Screening tests:Screening tests:

to predict PET and superimposed preeclampsiato predict PET and superimposed preeclampsia

on chronic hypertension.on chronic hypertension.

(1) US(1) US

it is quick ,non-invasive and inexpensive .it is quick ,non-invasive and inexpensive .

Uterine artery Doppler Uterine artery Doppler ::

analysis of its waveform is an early predictor ofanalysis of its waveform is an early predictor of

poor placental perfusion and development of PET , poor placental perfusion and development of PET ,

there is there is resistance circulation with notchresistance circulation with notch..

Its predictive value is greater at 24 weeks or more.Its predictive value is greater at 24 weeks or more.

Page 14: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Uterine art. Doppler in PET

diastolic notch

Page 15: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

(2) Biochemical tests

in preeclampsia : * HB , and Hematocrit concentrations. * CBC with platelets count. * serum uric acid . * endothelial activation markers are increased. * urinary excretion of Ca and microalbuminuria

Page 16: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

in severe chronic hypertension: * urine analysis. * 24h urine for protein , creatinine clearance, catecholamine metabolites and free cortisol. * bl. Urea and electrolytes as Na & k. * Lupus anticoagulant and anticardiolipin in APS. * serum lipids.

in addition (3) fundoscopy. (4) ECG & ECHO.

(5) X ray chest.

Page 17: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Symptoms & Signs

Page 18: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.
Page 19: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

* Criteria of severe preeclampsia = blood pressure : > 160 mmHg systolic or

• > 110 mm Hg diastolic• = Proteinuria: > 3 g in 24 hours

• = Persistent and severe cerebral or visual

disturbances (headache, blurred vision)• = Persistent and severe epigastric pain or

right upper quadrant pain.•

= Pulmonary edema or cyanosis. = Oliguria ( < 500 ml urine / 24 hour). = Eclampsia ( grand mal seizures). = HELLP syndrome.

Page 20: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Maternal and fetal assessment:

* the GA at which woman present with hypertension is an important factor in establishing risk . Late onset hypertension after 37weeks rarely result

in serious maternal or fetal complications.

* Superimposed pre eclampsia on chronic hypertension is diagnosed by identifying proteinuria, raised uric acid levels or failing platelets count .

chronic hypertension is associated with preeclampsia in 20% and abruptio placenta in 2%.

Page 21: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

* Uterine artery Doppler velocity waveforms is used to assess risk .

* bl.pressure and urine analysis are checked every 2 weeks. sudden and profound rise should alert the

clinician to the possibility of PET.

* high uric acid and low platelet count may pre –date proteinuria by some weeks.

Page 22: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Management

Pre eclamptic Toxaemia A) PET remote from term Early onset PET is associated with :

a. placental insufficiency resulting in IUGR and fetal death. Therefore ; Fetal Wellbeing must be carefully considered. 1. monitoring of fetal movements. 2. serial symphesis -fundal height . 3. serial US to confirm fetal growth ,AF volume and Umbilical A. Doppler waveform .

Page 23: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

b. involvement of other organ systems

resulting in increased maternal morbidity and mortality.

1.serial platelets count as platelets are consumed due to endothelial activation. Thrompocytopenia <100.000/ml. delivery should be considered.

2.increased HB and haematocrit values indicate hypovolaemia.

3.clotting abnormalities indicate DIC..

Page 24: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

4.raised uric acid a measure of fine renal tubular function is used to assess severity of the disease. raised urea and creatinine indicate late renal involvement . 5.severe proteinuria > 3g /24 hours urine resulting in fall of circulating albumin and increasing the risk of pulmonary edema.

Page 25: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

5.HELLP syndrome it is severe variant of PET, Haemolysis , Elevated Liver enzymes and Low Platelets .

PET can cause subcapsular hematoma, liver rupture and hepatic infarction which result in raised liver transaminases as AST indicating hepatocellular damage and liver involvement and the need to consider delivery.

Page 26: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Delivery :

should be considered once fetal lung maturity is likely ( at 32 weeks gestation) ,especially if either

multi-organ involvement or fetal compromise is

proved.

Corticosteroids are given to enhance fetal lung maturity. Steroid therapy may enhance recovery from HEELP syndrome.

Delivery before term is usually by CS .such patients are risk of thromboembolism and should be given prophylactic SC heparin and stockings.

Page 27: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Indications of termination of pregnancy

in PET :

1. uncontrollable hypertension. 2. deteriorating liver or renal function. 3. progressive fall in platelets. 4. neurological complications as cerebral Hge.

5. deteriorating fetal condition as non-reactive CTG.

Page 28: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

B) PET near term Lat onset preeclampsia rarely results in serious morbidity to mother or fetus . Drug therapy should be considered:

a) antihypertensive the aim is to lower the bl. pressure and lower the risk of maternal cerebrovacular accident without uterine bl. flow and compromising the fetus.

Page 29: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

1. Labetolol

ą &β blockers . can be given IV and orally. safe during pregnancy. 2. Methyldopa centrally acting agent. very safe during pregnancy. only given orally . takes 24 h for its effect. 3. Nifedipine is Ca channel blocker . with rapid onset of action. cause severe headache.

Page 30: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

NB:

Diuretics ,Angiotensin-converting enzyme (ACE)

inhibitors and β-blockers are contraindicated .

b) Low dose aspirin results in significant reduction in preeclampsia associated fetal death and preterm delivery.

c) for prophylaxis Ca , fish oil , antioxidants , vit. C , vit. E

Page 31: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Management of severe fulminating preeclampsia and impending eclampsia :

1. IV antihypertensive Hydralazine / labetolol IV infusion titration rapidly against changes in the blood pressure . 2. Anticonvulsant therapy Magnesium Sulfate : * it is the anticonvulsant of choice as ttt. of eclampsia and also as prophylaxis which reduce the risk of fits to half. Diazepam and phenytoin can be used but less effective .

Page 32: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

* mode of action

= anticonvulsant. = muscle relaxant. =vasodilator. reduce the intracerebral ischaemia. * dose 2 g IV as a loading dose then 1-2 g / h as maintenance infusion.

* toxicity is detected by : absence of the patellar reflexes. respiratory arrest . may be cardiac arrest. * antidote is: 10 ml of 10% Ca gluconate.

Page 33: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

3. Fluid management a Folly′s catheter should be inserted and fluid balance recorded.

* oliguria without a rising serum urea or creatinine is a manifestation of severe PET and not renal failure. however , if creatinine or potassium rises , haemodialysis is necessary.

* diuretics should only be given if there are signs of pulmonary edema.

Page 34: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Postpartum Care * in severe PET and eclampsia, a severe type of

of eclamptic fits occur postpartum , intensive

monitoring is required for 48 h. after delivery. * bl. Pressure is frequently at its highest levels 3 -4 days after delivery . Therefore , antihypertensive therapy is need to be continued after discharge home.

Page 35: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

* a postnatal care visit 6 -8 w. is mandatory for

measuring bl.p , urine analysis , RFT, LFT and predisposing factors as thrompophilia or APS should be excluded.

* in women with severe chronic hypertension must be carefully monitored for at least 48h after delivery as they are at increased risk of renal failure , pulmonary edema and hypertensive encephalopathy.

Page 36: Hypertensive Disorders in Pregnancy Azza Alyamani Azza Alyamani Prof. of Obstetrics & Gynecology Prof. of Obstetrics & Gynecology.

Thank you